000 00991 a2200289 4500
005 20250517143005.0
264 0 _c20180625
008 201806s 0 0 eng d
022 _a1474-5488
024 7 _a10.1016/S1470-2045(17)30172-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPostow, Michael A
245 0 0 _aA step forward for patients with NRAS-mutant melanoma.
_h[electronic resource]
260 _bThe Lancet. Oncology
_c04 2017
300 _a414-415 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aGTP Phosphohydrolases
_xgenetics
650 0 4 _aHumans
650 0 4 _aMelanoma
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aMutation
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aSkin Neoplasms
700 1 _aChapman, Paul B
773 0 _tThe Lancet. Oncology
_gvol. 18
_gno. 4
_gp. 414-415
856 4 0 _uhttps://doi.org/10.1016/S1470-2045(17)30172-9
_zAvailable from publisher's website
999 _c26959613
_d26959613